Maidenuo Medical

Maidenuo Medical Group Co., Ltd. (hereinafter referred to as the "Group") was established on January 1, 2011. It is a diversified large-scale group company integrating R&D, production, sales, investment and financing, focusing on the medical and health industry. The head office has 46 branch companies and 23 offices nationwide, covering more than 2,000 hospital departments in all provinces, cities and counties except Hong Kong, Macao and Taiwan that perform minimally invasive interventional surgeries. It has a rich product line and a well-qualified staff team, and as a distributor, it enjoys high visibility in the industry.
The company's sales system primarily deals in Class II/III medical device consumables. In 2020, Maidenuo Medical Group was formally established in Suzhou, marking its entry into the medical device manufacturing field through a model of "self-developed R&D + equity participation + acquisition."
The Group's founding purpose is: relying on advanced medical technologies and products, combining independent R&D with technology introduction, driven by innovation as the core, and committed to developing into a specialized and industrialized group company that best meets market demand and clinical needs in China.
With a development strategy of "diversified operations," the Group has grown over the past decade into a large comprehensive group in the minimally invasive intervention field, boasting the country's leading sales network and covering the entire medical device industry chain—upstream investment and financing, midstream R&D and production, and downstream sales and services—with perfect matching and coordinated layout across the upstream, midstream and downstream segments.